| Today's Open | $7.81 |
|---|---|
| Previous Close | $7.51 |
| Daily Range | $7.50 - $7.83 |
| 52-Week Range | $6.95 - $13.50 |
| Market Cap | $1.7B |
| P/E Ratio | -20.86 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 7,044,713 |
| Average Daily Volume | 5,816,065 |
| Current FY EPS | -$0.12 |
Sector
Healthcare
Industry
Drugs
Arena Pharmaceuticals, Inc. (ARNA) Description
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/
News & Commentary
It's Official: Obesity Is a Disease
At least according to the American Medical Association.Healthcare Stocks Inching Lower; Weight Loss Drug-Makers Climbing After AMA Labels Obesity as Diseas
Healthcare Stocks Inching Lower; Weight Loss Drug-Makers Climbing After AMA Labels Obesity as DiseaseThe Top 5 Diseases Caused by Obesity
Obesity accounts for 21% of all health-care expenditures annually, and it's a leading risk factor for these five diseases.ARNA's Top Competitors
(1.33%)
(-2.29%)
(-2.58%)
(-3.32%)